|
|
|||
|
||||
OverviewThis book is a compilation of topics addressed by the ASA Biopharmaceutical Section work groups, including the etiology and evolution of the work groups, the work group guidelines and structure, and the statistical issues associated with clinical trials in clinical drug development programs. Full Product DetailsAuthor: Karl E. Peace (Georgia Southern University, Statesboro, USA) , Karl E. PeacePublisher: Taylor & Francis Inc Imprint: CRC Press Inc Volume: 106 Dimensions: Width: 21.00cm , Height: 2.50cm , Length: 28.00cm Weight: 0.725kg ISBN: 9780824782900ISBN 10: 0824782909 Pages: 384 Publication Date: 11 December 1989 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1. ASA Biopharmaceutical Section Work Groups 2. Summarization, Analysis, and Monitoring of Adverse Experiences 3. Two Treatment Crossover Designs 4. Active Control Equivalence Studies 5. Optimization in Clinical Trials and Combination Drug Development 6. Dosing in the Elderly 7. Intention to Treat in Clinical Trials 8. Dual Control Groups in Rodent Carcinogenicity StudiesReviewsAuthor InformationKarl E. Peace Tab Content 6Author Website:Countries AvailableAll regions |